While the push to get Americans vaccinated continues across the country, preliminary data has emerged that lab-created monoclonal antibodies could be a treatment for COVID-19.
Since the beginning of the pandemic, little has been met with more anticipation (or hesitancy) than the promise of a COVID-19 vaccine. However, by mid-November 2020, less than a year after SARS-CoV-2 gained global recognition as a public health threat, this “promise” has moved from speculation to possibility, and the news has everyone talking.
The United Nations’ Global Goal 3 aims to ensure everyone, everywhere has access to good health and well-being. Early detection of potential outbreaks plays an essential role in ensuring public health. Join Global Citizen in taking action on this issue and more here.
